eFFECTOR Therapeutics Announces Closing of 75 Million Registered Direct Offering Priced AtTheMarket Under Nasdaq Rules
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for…